Sof marja: Personalis, Inc. (PSNL)

Personalis Inc (PSNL) - korporativ logo

Personalis, Inc. yuqori aniqlikdagi genomik diagnostikasi tufayli aniqlik onkologiyasi sohasida etalon sifatida tan olingan. Savdo marjalari foyda dinamikasini aks ettiradi va qiymat -147.70 darajasida saqlanmoqda. Kompaniya klinika va sog'liqni saqlash gigantlari uchun genetik testlar orqali barqaror talabni ta'minlaydi, sekvensirlashdagi tor ixtisoslashuvi esa innovatsion suyuq biopsiya IT platformasining joriy etilishi bilan muvozanatga keltirilgan.

Personalis Genomics (PSNL) Sotuvning sof rentabelligi: 04.07.2022 - 19.11.2026 davri uchun

Personalis Corp (PSNL) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Personalis, Inc.
Personalis Inc ishlab chiqargan mahsulot

Genomik o'sma profillashning kengayishi va farmatsevtika hamkorliklari orqali diagnostika testlarining ko'payishi Personalis, Inc. (PSNL) kompaniyasining monetizatsiya samaradorligiga bevosita ta'sir qiladi. Sof savdo marjasini tahlil qilish orqali investor yakuniy foydaning tushumga nisbatini baholaydi, bu esa boshqaruvning tijorat o'sishini haqiqiy daromadga aylantirish qobiliyatini va ushbu ko'rsatkich dinamikasi orqali operatsion risklarni nazorat qilish imkoniyatini belgilaydi.

Personalis, Inc. (PSNL) raqobatchilari

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi ERAS|DCTH: Sof foyda bo'yicha sotuv rentabelligi|YmAbs - Kompaniyaning sof rentabelligi|aurabiosciences.com (AURA) - Sof marja|Candel Therapeutics Inc. - Sof foyda normasi|Sof marja Accuray Inc.|Sof marja SELLAS Life Sciences Group SLS|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)